Cargando…
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanis...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097452/ https://www.ncbi.nlm.nih.gov/pubmed/30115078 http://dx.doi.org/10.1186/s13046-018-0861-9 |
_version_ | 1783348307527991296 |
---|---|
author | Li, Jie Liu, Qian Liu, Zihao Xia, Qian Zhang, Zihao Zhang, Rui Gao, Taihong Gu, Guangyan Wang, Yanan Wang, Dan Chen, Xiuyang Yang, Yihang He, Dong Xin, Tao |
author_facet | Li, Jie Liu, Qian Liu, Zihao Xia, Qian Zhang, Zihao Zhang, Rui Gao, Taihong Gu, Guangyan Wang, Yanan Wang, Dan Chen, Xiuyang Yang, Yihang He, Dong Xin, Tao |
author_sort | Li, Jie |
collection | PubMed |
description | BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanisms of KPNA2 in tumorigenesis and progression are largely unknown. Especially its potential roles in the metabolic transformation of tumors still remain to be explored. METHODS: The expressions of KPNA2 in glioblastoma and normal human brain samples were analyzed by immunohistochemical analysis. The activities of key enzymes in glycolysis, the production of lactate acid and glucose uptake were investigated by colorimetry. GLUT-1 expression was measured by flow cytometry. CCK8 was used to examine the cell viability in vitro, and the xenograft models in nude mice were established to explore the roles of KPNA2 in vivo. In addition, Co-IP, subcellular fractionation, western blot, immunofluorescence and luciferase assay were used to investigate the internal connection between KPNA2, c-myc and E2F1. RESULTS: In the present study, we found that KPNA2 was highly expressed in the glioma compared to the normal brain tissues. Level of KPNA2 was an independent predictor of prognosis in the glioma patients. Knockdown of KPNA2 in the glioblastoma cell lines U87 and U251 decreased deoxyglucose uptake, activities of the key glycolytic enzymes and lactate production. The level of oxidative phosphorylation (OXPHOS) was moderately decreased. Additioanlly, tumor proliferation and invasiveness were concomitantly downregulated. We have identified c-myc as a potential mediator of KPNA2. Aberrant expression of KPNA2 significantly changed the subcellular distribution of c-myc as well as its expression level. E2F1, another key cargo protein of KPNA2, was further identified to play a potential role in regulating the transcription of c-myc by KPNA2. CONCLUSIONS: Our findings suggested that KPNA2, a potential tumor oncogene, performs its function in part via regulating cellular metabolism through c-myc signaling axis. It would provide a possible explanation for Warburg effect and thus offer a new perspective to the roles of KPNA2 in gliomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0861-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6097452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60974522018-08-20 KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc Li, Jie Liu, Qian Liu, Zihao Xia, Qian Zhang, Zihao Zhang, Rui Gao, Taihong Gu, Guangyan Wang, Yanan Wang, Dan Chen, Xiuyang Yang, Yihang He, Dong Xin, Tao J Exp Clin Cancer Res Research BACKGROUND: Cancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanisms of KPNA2 in tumorigenesis and progression are largely unknown. Especially its potential roles in the metabolic transformation of tumors still remain to be explored. METHODS: The expressions of KPNA2 in glioblastoma and normal human brain samples were analyzed by immunohistochemical analysis. The activities of key enzymes in glycolysis, the production of lactate acid and glucose uptake were investigated by colorimetry. GLUT-1 expression was measured by flow cytometry. CCK8 was used to examine the cell viability in vitro, and the xenograft models in nude mice were established to explore the roles of KPNA2 in vivo. In addition, Co-IP, subcellular fractionation, western blot, immunofluorescence and luciferase assay were used to investigate the internal connection between KPNA2, c-myc and E2F1. RESULTS: In the present study, we found that KPNA2 was highly expressed in the glioma compared to the normal brain tissues. Level of KPNA2 was an independent predictor of prognosis in the glioma patients. Knockdown of KPNA2 in the glioblastoma cell lines U87 and U251 decreased deoxyglucose uptake, activities of the key glycolytic enzymes and lactate production. The level of oxidative phosphorylation (OXPHOS) was moderately decreased. Additioanlly, tumor proliferation and invasiveness were concomitantly downregulated. We have identified c-myc as a potential mediator of KPNA2. Aberrant expression of KPNA2 significantly changed the subcellular distribution of c-myc as well as its expression level. E2F1, another key cargo protein of KPNA2, was further identified to play a potential role in regulating the transcription of c-myc by KPNA2. CONCLUSIONS: Our findings suggested that KPNA2, a potential tumor oncogene, performs its function in part via regulating cellular metabolism through c-myc signaling axis. It would provide a possible explanation for Warburg effect and thus offer a new perspective to the roles of KPNA2 in gliomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0861-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-16 /pmc/articles/PMC6097452/ /pubmed/30115078 http://dx.doi.org/10.1186/s13046-018-0861-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Jie Liu, Qian Liu, Zihao Xia, Qian Zhang, Zihao Zhang, Rui Gao, Taihong Gu, Guangyan Wang, Yanan Wang, Dan Chen, Xiuyang Yang, Yihang He, Dong Xin, Tao KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title_full | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title_fullStr | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title_full_unstemmed | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title_short | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
title_sort | kpna2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097452/ https://www.ncbi.nlm.nih.gov/pubmed/30115078 http://dx.doi.org/10.1186/s13046-018-0861-9 |
work_keys_str_mv | AT lijie kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT liuqian kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT liuzihao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT xiaqian kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT zhangzihao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT zhangrui kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT gaotaihong kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT guguangyan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT wangyanan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT wangdan kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT chenxiuyang kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT yangyihang kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT hedong kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc AT xintao kpna2promotesmetabolicreprogramminginglioblastomasbyregulationofcmyc |